Lexeo Therapeutics Inc (LXEO) returns
Lexeo Therapeutics returns over 1 year
$1,000 invested in Lexeo Therapeutics one year ago was worth $332.98 at the close on October 30, 2026, with dividends reinvested. The same $1,000 in the S&P 500 (SPY) became $1,124.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -7.1% | — | $928.99 | -0.9% |
| 3 months | -27.8% | — | $721.84 | +2.1% |
| Year to date | -68.4% | — | $316.21 | +11.7% |
| 1 year | -66.7% | — | $332.98 | +12.4% |
Lexeo Therapeutics return by calendar year
| Year | LXEO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -68.4% | +11.7% | -80.1% |
| 2025 | +50.9% | +17.7% | +33.2% |
| 2024 | -51.0% | +24.9% | -75.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Lexeo Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.